Rockefeller Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Sell |
|
|||||
|
2025
Q2 | $15.6M | Sell |
|
|||||
|
2025
Q1 | $42.9M | Sell |
|
|||||
|
2024
Q4 | $67.5M | Sell |
|
|||||
|
2024
Q3 | $103M | Sell |
|
|||||
|
2024
Q2 | $104M | Sell |
|
|||||
|
2024
Q1 | $101M | Sell |
|
|||||
|
2023
Q4 | $92.8M | Buy |
|
|||||
|
2023
Q3 | $85.6M | Buy |
|
|||||
|
2023
Q2 | $56.5M | Buy |
|
|||||
|
2023
Q1 | $62M | Sell |
|
|||||
|
2022
Q4 | $54.5M | Sell |
|
|||||
|
2022
Q3 | $55.7M | Sell |
|
|||||
|
2022
Q2 | $48.3M | Sell |
|
|||||
|
2022
Q1 | $64M | Buy |
|
|||||
|
2021
Q4 | $54.4M | Sell |
|
|||||
|
2021
Q3 | $52.9M | Sell |
|
|||||
|
2021
Q2 | $106M | Buy |
|
|||||
|
2021
Q1 | $60.2M | Buy |
|
|||||
|
2020
Q4 | $52.5M | Buy |
|
|||||
|
2020
Q3 | $58.5M | Sell |
|
|||||
|
2020
Q2 | $82.2M | Sell |
|
|||||
|
2020
Q1 | $65.7M | Sell |
|
|||||
|
2019
Q4 | $58.3M | Sell |
|
|||||
|
2019
Q3 | $65.7M | Sell |
|
|||||
|
2019
Q2 | $75.3M | Buy |
|
|||||
|
2019
Q1 | $57.9M | Sell |
|
|||||
|
2018
Q4 | $53.2M | Sell |
|
|||||
|
2018
Q3 | $70.6M | Sell |
|
|||||
|
2018
Q2 | $60.9M | Sell |
|
|||||
|
2018
Q1 | $61.4M | Buy |
|